Biofrontera AG BIFRF
OTC PK
| 03/31/2026 | 03/31/2026 | 09/30/2025 | 09/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -28.41% | 26.12% | 7.43% | 7.43% | -14.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -28.41% | 26.12% | 7.43% | 7.43% | -14.52% |
| Cost of Revenue | -48.98% | 33.15% | 51.24% | 51.24% | -53.27% |
| Gross Profit | -20.89% | 24.57% | -5.67% | -5.67% | 4.62% |
| SG&A Expenses | 7.80% | 16.64% | -23.74% | -23.74% | -3.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -17.05% | 18.10% | 4.44% | 4.44% | -36.65% |
| Operating Income | -98.76% | 104.66% | 4.95% | 4.95% | 87.23% |
| Income Before Tax | -93.27% | 120.19% | 57.85% | 57.85% | 91.91% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -93.27% | 120.19% | 57.73% | 57.73% | 91.91% |
| Earnings from Discontinued Operations | -- | 165.54% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 260.76% | 260.76% | 57.73% | 57.73% | 124.27% |
| EBIT | -98.76% | 104.66% | 4.95% | 4.95% | 87.23% |
| EBITDA | -92.94% | 139.69% | 6.24% | 6.24% | 90.53% |
| EPS Basic | 263.73% | 263.73% | 57.49% | 57.49% | 101.13% |
| Normalized Basic EPS | -94.28% | 120.33% | 57.61% | 57.61% | 99.62% |
| EPS Diluted | 263.73% | 263.73% | 57.49% | 57.49% | 101.13% |
| Normalized Diluted EPS | -94.28% | 120.33% | 57.61% | 57.61% | 99.62% |
| Average Basic Shares Outstanding | -0.85% | -0.85% | -0.64% | -0.64% | 2,050.59% |
| Average Diluted Shares Outstanding | -0.85% | -0.85% | -0.64% | -0.64% | 2,050.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |